Scientific Publication

Retrospective analysis of radiotherapy plans for prostate cancer after revision of MRI targeted lesions detected by Quantib

ANNUAL MEETING OF THE ITALIAN SOCIETY OF URO-ONCOLOGY (SIURO), 2023

Petrucci et al,

October 3, 2023

Retrospective evaluation coverage of therapy plans in 5 subjects with prostate cancer who underwent hypofractionated radiotherapy.
These preliminary results showed that Quantib can assist the identification of target lesions, and confirmed optimal radiotherapy coverage of the target volume and a subsequent biochemical response at minimal follow-up.

To understand how you use our Website and to improve your experience, we collect certain important information (e.g., cookies). To learn about what we collect and why read our Privacy Policy.

Essential Information

This collected information is necessary to provide you with the critical features available on our Website. Because this information is essential to your experience, you are unable to alter these settings and still use the Website.

Accept All Reject Non-Essential